The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.
Objective. Cervical cancer patients who had an abandoned radical hysterectomy were evaluated for preoperative clinical predictors, complication rates, and outcomes. Study Design. IRB approval was obtained for this retrospective analysis and chart review was performed. Results. From 268 women with early-stage (IA2 to IIA) cervical cancer, 19 (7%) had an abandoned hysterectomy for finding grossly positive lymph nodes (84%) or pelvic spread of tumor (16%). No clinical characteristics clearly identified women preoperatively at risk of having an abandoned hysterectomy. In the abandoned group, 26% suffered major morbidities, compared to 34% in the completed group (OR 0.69, [CI 0.16-2.57], P = .789). Thirty-seven percent recurred in the abandoned group, compared to 18% in the completed group (P = .168). Overall survival in the abandoned group was 73% versus 80% in the completed group (P = .772). Conclusion. The practice of abandoning a planned radical hysterectomy for unexpected metastatic disease may not worsen the outcome.
Gray
Heidi J
HJ
Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Seifert
Erin
E
Sal Y Rosas
Victor G
VG
Nicandri
Katrina F
KF
Koh
Wui-Jin
WJ
Goff
Barbara A
BA
Gynecol Oncol. 2008 Apr;109(1):53-8
18255127
Cancer. 1991 Jul 15;68(2):272-7
2070325
J Clin Oncol. 1999 Jan;17(1):41-5
10458216
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Gynecol Oncol. 2004 Oct;95(1):204-7
15385133
Gynecol Oncol. 1999 Sep;74(3):436-42
10479506
Gynecol Oncol. 2007 Jul;106(1):29-34
17482666
Cancer. 2005 Dec 1;104(11):2484-91
16270319
Cancer. 1998 Jun 1;82(11):2241-8
9610705
Int J Gynecol Cancer. 2005 May-Jun;15(3):498-502
15882176
Int J Gynecol Cancer. 1995 Jul;5(4):250-256
11578485
Cancer. 2001 Jun 15;91(12):2214-21
11413508
J Clin Oncol. 2000 Apr;18(8):1606-13
10764420
Gynecol Oncol. 2008 Apr;109(1):43-8
18234297
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1335-42
18355976
Eur J Obstet Gynecol Reprod Biol. 1992 Nov 19;47(2):147-51
1459328
J Clin Oncol. 2001 Sep 1;19(17):3745-9
11533097
Lancet. 1997 Aug 23;350(9077):535-40
9284774
J Clin Oncol. 2005 Oct 20;23(30):7428-36
16234510
Gynecol Oncol. 2006 Sep;102(3):563-72
16716379
Gynecol Oncol. 1990 Apr;37(1):78-81
2323617
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):37-42
2912956
Gynecol Oncol. 2000 Dec;79(3):350-6
11104604
Int J Radiat Oncol Biol Phys. 1983 Apr;9(4):445-55
6853249